Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
| Market Capitalization | $44.3443 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.052 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.42 |
| EBITDA | -20,229 |
| Profit Margin | 0 |
| Operating Margin TTM | -1.9449 |
| Return on Assets TTM | -0.3128 |
| Return on Equity TTM | -1.4452 |
| Revenue TTM | 11,515 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2017-12-31 | 2,593.5 | 1,459.63 | 1,133.87 | |
| 2018-12-31 | 6,382.09 | 3,481.14 | 2,900.95 | |
| 2019-12-31 | 8,396.48 | 4,756.32 | 3,640.16 | |
| 2020-12-31 | 25,055 | 13,532 | 11,523 | |
| 2021-12-31 | 11,630 | 7,174 | 4,456 | 25,529 |
| 2022-12-31 | 10,535 | 4,563 | 5,972 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2017-12-31 | 328.63 | 12,015.69 | 7,988.71 | 6,935.54 | 0 | 4,100.08 |
| 2018-12-31 | 4,372.02 | 36,184.2 | 19,576.03 | 4.16 | 14,847.77 | 18,086.531 |
| 2019-12-31 | 1,234.11 | 43,874.34 | 11,771.01 | 0 | 23,130 | |
| 2020-12-31 | 130,548 | 52,816 | 0 | 84,222 | ||
| 2021-12-31 | 7,978 | 36,940 | 19,055 | 968 | 92,139 | |
| 2022-12-31 | 3,015 | 25,419 | 15,921 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2017-12-31 | -1,711.177 | -390.027 | 304.604 | |||
| 2018-12-31 | -6,545.849 | -4,322.589 | 4,043.392 | |||
| 2019-12-31 | -13,447 | -5,445 | -3,139 | |||
| 2020-12-31 | -15,030 | -10,889 | 44,043 | 44,890 | ||
| 2021-12-31 | -45,724 | -18,036 | -36,912 | 44,890 | 7,978 | |
| 2022-12-31 | -8,971 | -4,679 | 7,978 | 3,015 |